New method to detect human growth hormone for anti-doping testing

September 4, 2017
Credit: Macquarie University

A study led by researchers from Macquarie University has unveiled another way to detect whether a person has taken human growth hormone (GH), by tracking protein levels. Specifically, the researchers used proteomics – the study of proteins and their interactions – to see which proteins had their levels altered when a person takes recombinant human growth hormone, the artificially developed version of the hormone that can be abused by athletes as a performance enhancer.

"We were able to detect changes in the levels of a group of eight proteins found in human blood plasma when a person has taken recombinant human growth . Six of these proteins have previously not been known to be affected by GH administration in human studies," said Dr Alamgir Khan from Macquarie University who oversaw the research.

"We found two proteins, ApoL1 and fetuin-A, that provide evidence of active hormone administration, while another protein called vitamin D-binding protein, could be particularly useful, due to the fact that its levels actually decreased as a result of administering the hormone and tended to stay at lower levels for a longer time. This means that anti-doping officials would have a longer period from when the athlete took the hormone to detect that something was amiss," he added.

The two current methods used by anti-doping organisations to detect the hormone performance enhancer include a that identifies changes in the ratio of the artificially and naturally produced versions of the growth , and another test that detects increased levels of two molecules after taking the hormone.

"The problem with these current tests is that they need to be done shortly after someone has taken the hormone, and there is variability in the test results among individuals. Our findings identify other blood markers which could potentially supplement existing biomarker tests providing more confidence to anti-doping authorities, athletes and the public for enjoying cleaner sports," explained Dr Khan.

Recombinant , which works by stimulating cell growth and production, is licenced for people who have a hormone deficiency, but is also one of the many performance enhancing substances abused by athletes. The researchers say that their results could also herald the development of even more robust and sensitive testing methods for the detection of an array of artificial enhancers.

"The proteomics approach used in this study could also be applied in developing more rigorous testing for other performance enhancers such as designer peptides", Dr Khan concluded.

Key to the study's findings was use of the gel technology and advanced mass spectrometry techniques available at the Australian Proteome Analysis Facility (APAF) located at the Macquarie University North Ryde campus in Sydney.

"Coupled with a well-designed clinical study, the research demonstrates the effectiveness of high quality proteomic analysis in contributing towards the fight for cleaner sports," concluded APAF Director, Associate Professor Mark Molloy.

Explore further: Growth hormone related with signs of aging

More information: Plasma biomarker proteins for detection of human growth hormone administration in athletes, Scientific Reports, www.nature.com/articles/s41598-017-09968-7

Related Stories

Growth hormone related with signs of aging

June 16, 2014
The decreased production of growth hormone is caused by a physiological process known as somatopause, which practically affects the entire body, since it's involved in body composition, metabolism, bone mineral density and ...

Naturally produced testosterone gives female athletes 'significant' competitive edge

July 4, 2017
High levels of testosterone that are naturally produced by some elite female athletes give them a "significant" competitive edge in athletics events that depend on stamina and visuospatial abilities, reveals the first study ...

Blood doping doesn't work, at least not in amateurs: study

June 30, 2017
Use of the EPO hormone to boost athletic performance did nothing for amateur cyclists in a road-race trial, according to a study Friday that questioned whether blood doping is worth the risk.

Recommended for you

Thousands of new microbial communities identified in human body

September 20, 2017
A new study of the human microbiome—the trillions of microbial organisms that live on and within our bodies—has analyzed thousands of new measurements of microbial communities from the gut, skin, mouth, and vaginal microbiome, ...

Study finds immune system is critical to regeneration

September 20, 2017
The answer to regenerative medicine's most compelling question—why some organisms can regenerate major body parts such as hearts and limbs while others, such as humans, cannot—may lie with the body's innate immune system, ...

Immune cells produce wound healing factor, could lead to new IBD treatment

September 20, 2017
Specific immune cells have the ability to produce a healing factor that can promote wound repair in the intestine, a finding that could lead to new, potential therapeutic treatments for inflammatory bowel disease (IBD), according ...

As men's weight rises, sperm health may fall

September 20, 2017
(HealthDay)—A widening waistline may make for shrinking numbers of sperm, new research suggests.

New model may help science overcome the brain's fortress-like barrier

September 19, 2017
Scientists have helped provide a way to better understand how to enable drugs to enter the brain and how cancer cells make it past the blood brain barrier.

Cell-based therapy success could be boosted by new antioxidant

September 19, 2017
Cell therapies being developed to treat a range of conditions could be improved by a chemical compound that aids their survival, research suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.